Trends and Perspective of Metabolic Syndrome

  • Nnodim Johnkennedy Department of Medical Laboratory Science, Faculty of Health Science, Imo State University Owerri, Nigeria
  • Njoku-Obi Treasure Department of Microbiology, Faculty of Sciences, Imo State University Owerri, Imo State, Nigeria
  • Ikem Amarachi Promise Department of Medical Laboratory Science, Faculty of Health Science, Imo State University Owerri, Nigeria
Keywords: Trends, Metabolic Syndrome, Perspective

Abstract

Overweight, sedentary lifestyles, and some degree of insulin resistance are only a few of the traits linked with individuals who have the metabolic syndrome. Additional risk factors include a sedentary or inactive lifestyle, the use of psychiatric drugs, and excessive alcohol use. Weight gain and insulin resistance are connected with the metabolic syndrome. The most effective methods of losing weight are low-calorie diets and increased physical activity. Preliminary research indicates that individuals who consume a paleolithic diet may reduce three of the five quantitative risk factors for cardiovascular disease.

References

Alessi, M. C., & Juhan-Vague, I. (2008). Metabolic syndrome, haemostasis and thrombosis. Thrombosis and haemostasis, 99(06), 995-1000.

Cuspidi, C., Sala, C., & Zanchetti, A. (2008). Metabolic syndrome and target organ damage: role of blood pressure. Expert review of cardiovascular therapy, 6(5), 731-743.

Giovannucci, E. (2007). Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. The American journal of clinical nutrition, 86(3), 836S-842S.

Grundy, S. M. (2008). Metabolic syndrome pandemic. Arteriosclerosis, thrombosis, and vascular biology, 28(4), 629-636.

Hernandez-Baixauli, J., Quesada-Vázquez, S., Mariné-Casadó, R., Gil Cardoso, K., Caimari, A., Del Bas, J. M., & Baselga-Escudero, L. (2020). Detection of early disease risk factors associated with metabolic syndrome: a new era with the NMR metabolomics assessment. Nutrients, 12(3), 806.

Huang, P. L. (2005). Unraveling the links between diabetes, obesity, and cardiovascular disease. Circulation research, 96(11), 1129-1131.

Ito, M. K. (2004). The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin. Annals of Pharmacotherapy, 38(2), 277-285.

Meigs, J. B. (2004). Metabolic syndrome: in search of a clinical role. Diabetes Care, 27(11), 2761-2763.

Saklayen, M. G. (2018). The global epidemic of the metabolic syndrome. Current hypertension reports, 20(2), 1-8.

Shields, T. M., & Hennekens, C. H. (2004). Management of metabolic syndrome: aspirin. Endocrinology and Metabolism Clinics, 33(3), 577-593.

Simmons, R. K., Alberti, K. G. M. M., Gale, E. A. M., Colagiuri, S., Tuomilehto, J., Qiao, Q., ... & Roglic, G. (2010). The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia, 53(4), 600-605.

Türkoglu, Ç., Duman, B. S., Günay, D., Çagatay, P., Özcan, R., & Büyükdevrim, A. S. (2003). Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obesity surgery, 13(5), 699-705.

Welty, F. K, Alfaddagh A, Elajami T. K. (2016).. Targeting inflammation in metabolic syndrome. Transl Res. 167(1):257-80

Xu, H., Li, X., Adams, H., Kubena, K., & Guo, S. (2018). Etiology of metabolic syndrome and dietary intervention. International journal of molecular sciences, 20(1), 128.

Published
2022-03-31
How to Cite
Johnkennedy, N., Treasure, N.-O., & Promise, I. A. (2022). Trends and Perspective of Metabolic Syndrome. Journal La Lifesci, 3(2), 92-96. https://doi.org/10.37899/journallalifesci.v3i2.617